S

Salient Pharmaceuticals Incorporated

10 employees

Salient is developing CASAD™, a proprietary composition proven to adsorb a range of toxins and inflammatory proteins.

Basic info

Industry

biotechnology

Sectors

Biotechnology
Health Care
Pharmaceutical
Biopharma

Date founded

2007

Funding rounds raised

Total raised

$2M

from 2 investors over 2 rounds

S

Salient Pharmaceuticals Incorporated raised undisclosed on August 18, 2011

Investors: Texas Venture Labs

S

Salient Pharmaceuticals Incorporated raised $2M on January 29, 2010

Investors: Texas Wide Open for Business

FAQ